tirzepatide weight loss efficacy vs semaglutide of versus in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial | Diabetologia In adults with obesity but

The gradual escalation lets the GI tract adapt and dramatically improves tolerability

The concern is grounded in a specific physiological reality: up to 40% of total weight lost on high-efficacy GLP-1 medications is lean body mass, not fat, according to body composition studies cited in recent Harvard Science Review analysis and a Nature Reviews Endocrinology correspondence published in 2026

You can expect to regain much (if not all) of the weight youve lost

This typically resolves upon lowering the dosage or discontinuing use

Discuss the prohibited status of peptides under WADA, National Collegiate Athletic Association (NCAA), many professional sports, and potential sanctions